Compare Cytokinetics Inc (CYTK) vs Snowflake Inc (SNOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Snowflake Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Snowflake Inc trades at $332.69 (market cap $116.01B). The key difference: Snowflake Inc is far larger — about 10.9× Cytokinetics Inc's market cap, and Snowflake Inc is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | SNOW | |
|---|---|---|
Market Cap | $10.63B | $116.01B |
Sector | Technology | Technology |
52-Week High | $87.26 | $334.70 |
52-Week Low | $34.31 | $121.11 |
Enterprise Value | $10.74B | $115.82B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →
